Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling in the Intensive Care Unit
Early Rehabilitation Using Functional Electrical Stimulation Assisted Supine Cycling Effect on Muscle Mass, Strength, Biomarkers, and Functional Outcomes as Compared With Conventional Exercise and Early Mobilization Alone in Critically Ill Patients in the Intensive Care Unit
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Rachel Dirks, PhD
- Phone Number: 559-459-4029
- Email: rdirks@communitymedical.org
Study Locations
-
-
California
-
Fresno, California, United States, 93721
- Recruiting
- Community Regional Medical Center
-
Contact:
- Paul Smith
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- ≥ 18 years of age
- Admitted to the ICU with a predicted ICU length of stay ≥ 4 days
- Expected to survive the ICU stay
- Expected to receive mechanical ventilation > 48 hours
- Able to perform physical outcome measures pre-morbidly (with or without an assisted device)
Exclusion Criteria:
- Proven or suspected neuromuscular weakness affecting the legs (eg- stroke or Guillain-Barré syndrome)
- Lower limb amputation(s)
- Assessed by medical staff as approaching imminent death or withdrawal of medical treatment within 36 hours
- Pregnancy
- Body mass index > 40
- Presence of external fixator or superficial metal in lower limb
- Open wounds or skin abrasions at electrode application points
- Presence of pacemaker or implanted defibrillator
- Transferred from another ICU after >48 hours of consecutive mechanical ventilation
- Lower limb malignancy
- Pre-existing intellectual disability or cognitive impairment limiting the ability to accurately follow instructions
- Body habitus unable to fit the bike
- Palliative goals of care
- Unable to participate in FESC within 48 hours of ICU admission due to logistic reasons or due to failure in daily screening for participation
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Functional electrical stimulation assisted supine cycling
Patients will start functional electrical stimulation assisted supine cycling (FESC) within 48 hours of ICU admission and will undergo up to 1 hour of supine cycling daily, 5 days per week for 28 days, or until discharge from ICU.
|
A supine cycle ergometer attached to a six-channel stimulator will be used for FESC.
Surface electrodes will be applied to the hamstrings, quadriceps, and calf muscles on both legs.
Muscles will be stimulated at specific stages throughout the cycling phase.
Each session will start with a 1 minute motor-driven passive cycling warm-up at a rate of 20 revolutions per minute.
Patients will continue with passive, active-assisted, or active cycling, according to their level of participation.
If the patients stop cycling actively, the ergometer will revert to passive cycling.
These interventions will be based on the patient's alertness and medical stability, and includes activities to maintain or increase limb range of motion and strength, in and out of bed mobility, sit to stand, and transfer training, as well as assisted ambulation.
|
|
Active Comparator: Conventional early exercise and mobility interventions
Patients will undergo standard ICU exercise and mobility interventions.
|
These interventions will be based on the patient's alertness and medical stability, and includes activities to maintain or increase limb range of motion and strength, in and out of bed mobility, sit to stand, and transfer training, as well as assisted ambulation.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent change of rectus femoris cross-sectional area
Time Frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Ultrasound measurements will be done with patients in supine position with their leg in passive extension and neutral rotation.
|
Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Diaphragm muscle thickness
Time Frame: Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Thickness will be measured by ultrasound at the zone of apposition during inspiration or expiration using the intercostal approach.
|
Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
|
Muscle strength
Time Frame: Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge
|
Muscle strength will be assessed using the Medical Research Council Scale.
This muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum expected for that muscle.
Weaker muscles will range from 0-3 and stronger muscles will receive grades 4 or 5.
|
Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge
|
|
Muscle strength
Time Frame: Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge
|
Muscle strength will be assessed using hand-held dynamometry
|
Baseline (within 24 hours of enrollment), weekly in the ICU (up to a maximum of 28 days), at ICU and hospital discharge (an average of 11 and 15 days after admission, respectively), and at 90 days, 6 months, and 1 year post ICU discharge
|
|
Physical function
Time Frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Physical function will be assessed using the physical function in ICU (PFIT) test
|
Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
|
Physical function
Time Frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Physical function will be assessed using the functional status score in the ICU (FSS-ICU).
This score consists of 3 pre-ambulation categories (rolling; supine to sit transfer; and unsupported sitting) and 2 ambulation categories (sit to stand transfers; ambulation).
Each category is scored from 1 (total dependent assistance) to 7 (complete independence) with a total score range of 0-35 (0: unable to perform a task due to physical limitations or medical status).
|
Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
|
Physical function
Time Frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Physical function will be assessed using the short physical performance battery (SPPB)
|
Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
|
Physical function
Time Frame: Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
Physical function will be assessed using the six-minute walk test (6MWT)
|
Baseline (within 24 hours of enrollment), weekly during ICU admission (up to a maximum of 28 days), at ICU discharge (an average of 11 days after admission), and at hospital discharge (an average of 15 days after admission)
|
|
Quality of life
Time Frame: At hospital discharge (an average of 15 days after admission), and 90 days, 6 months, and 1 year post ICU discharge
|
Quality of life will be measured using the 36-item Short Health Survey (SF-36), which assess eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions.
Each item is scored on a 0-100 scale and items in the same category are averaged together to create the 8 scale scores, with 0 being the lowest score and 100 being the highest for each category.
|
At hospital discharge (an average of 15 days after admission), and 90 days, 6 months, and 1 year post ICU discharge
|
|
Cognition
Time Frame: At hospital discharge (an average of 15 days after admission)
|
Cognition will be assessed using the Montreal Cognitive Assessment (MoCA).
|
At hospital discharge (an average of 15 days after admission)
|
|
Hospital length of stay
Time Frame: Through hospital discharge, an average of 15 days
|
The total hospital length of stay for this admission will be calculated.
|
Through hospital discharge, an average of 15 days
|
|
ICU length of stay
Time Frame: Through ICU discharge, an average of 11 days
|
The total ICU length of stay for this admission will be calculated.
|
Through ICU discharge, an average of 11 days
|
|
Duration of mechanical ventilation
Time Frame: Through discontinuation of mechanical ventilation, an average of 10 days
|
The total length of time on mechanical ventilation
|
Through discontinuation of mechanical ventilation, an average of 10 days
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Paul D Smith, PT, DPT, Community Medical Centers
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Anticipated)
Primary Completion
Study Completion (Anticipated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2018015
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.